3 More FTSE 100 Shares To Avoid Market Madness: AstraZeneca plc, Severn Trent Plc and Smith & Nephew plc

Statistics show that shareholders in AstraZeneca plc (LON:AZN), Severn Trent Plc (LON:SVT) and Smith & Nephew plc (LON:SN) have avoided being shaken by big market swings.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Market analysts call these low-beta shares. Compared with the rest of the index, statistics show that they have previously been less likely to get carried away by either market surges or sell-offs.

Should these low-beta shares have a place in your portfolio today?

AstraZeneca

As a pharmaceuticals manufacturer, AstraZeneca‘s (LSE: AZN)(NYSE: AZN.US) customers have little choice whether to buy their products. This brings a high degree of certainty to the company’s future earnings. AstraZeneca uses these profits to pay a big dividend to its shareholders.

The result is that even in market declines, the AstraZeneca share price does not fall heavily. The large dividend provides an incentive for shareholders to continue holding and the reliable earnings stream prevents panic.

The forecast profits for the year put AstraZeneca shares on a 2013 P/E of 9.9, with an expected yield of 5.4%. A slight fall in earnings is expected for 2014.

Severn Trent

Water firm Severn Trent (LSE: SVT) provides and treats water and waste water in the UK. Due to the nature of the business, it has very dependable revenues. This brings reliable profits and dividends. When market speculators are looking for a stock to make money on in the short term, Severn Trent is not the type of share that they chase.

Severn Trent’s customers have little choice over whether to use the company’s services. As a result, it is difficult to envisage a situation where Severn Trent’s profits could fall suddenly.

The market clearly loves this and has awarded Severn Trent a premium rating. The shares trade at 20.1 times forecast earnings for 2013 and come with a prospective yield of 4.5%.

Smith and Nephew

Orthopaedic parts manufacturer Smith and Nephew (LSE: SN) is a great play on the ageing populations of developed countries. As the world’s wealthier nations get older, demand for hip/knee replacement surgery is rising.

After making $0.49 in earnings per share in 2007, Smith and Nephew is expected to make $0.76 this year. This is expected to increase again in 2014 to $0.84 per share.

That puts the shares today on a 2013 P/E of 16.5, falling to 15.0 times 2014 forecasts. The shares are expected to yield 2.1% this year, rising to 2.3% for 2014.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> David does not own shares in any of the above companies.

More on Investing Articles

Middle-aged Caucasian woman deep in thought while looking out of the window
Investing Articles

Should I buy these UK shares for my portfolio?

This Fool has been searching for ways to capitalise on the commodity moves via UK shares. Here’s what he’s watching.

Read more »

Illustration of flames over a black background
Investing Articles

Just released: April’s higher-risk, high-reward stock recommendation [PREMIUM PICKS]

Fire ideas will tend to be more adventurous and are designed for investors who can stomach a bit more volatility.

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

£9,000 in savings? Here’s a FTSE 100 stock I’d buy to target a £30,652 annual second income!

Our writer highlights one top FTSE 100 share that he thinks could help create a portfolio large enough for a…

Read more »

Light bulb with growing tree.
Investing Articles

62% down! Is the Ceres Power share price now a green energy bargain?

Annual results from the green energy firm showed a company on the cusp of doubling sales. So why has the…

Read more »

Investing Articles

3 mid-cap UK defence shares to consider buying in 2024

Defence budgets are soaring as global conflicts increase the threat landscape, so I'm examining the value proposition of three defence-related…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Hargreaves Lansdown investors have been buying dividend stocks BP and Shell. Should I?

Cherished dividend stocks BP and Shell have outperformed the FTSE 100 index so far in 2024. Paul Summers takes a…

Read more »

Young Asian man shopping in a supermarket
Dividend Shares

A 5% yield? Here’s the 3-year dividend forecast for Tesco shares

Jon Smith flags up the positive momentum for Tesco shares following the release of the full-year results and looks at…

Read more »

Investing Articles

Yields up to 12.3% 3 top shares investors should consider for a second income

Searching for ways to make a market-beating second income? These popular dividend stocks are worth serious consideration, says Royston Wild.

Read more »